IBSA PHARMA INC: Drug Recall
Recall #D-0334-2023 · 01/30/2023
Class II: Risk
Recall Details
- Recall Number
- D-0334-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- IBSA PHARMA INC
- Status
- Terminated
- Date Initiated
- 01/30/2023
- Location
- Parsippany, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- N/A
Reason for Recall
Subpotent Drug
Product Description
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0155-5
Distribution Pattern
Nationwide in the USA.
Other Recalls by IBSA PHARMA INC
- Class II: Risk 01/30/2023
- Class II: Risk 01/30/2023
- Class II: Risk 01/30/2023
- Class II: Risk 01/30/2023
- Class II: Risk 01/30/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.